<DOC>
	<DOC>NCT01258231</DOC>
	<brief_summary>This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.</brief_summary>
	<brief_title>Identification of Genomic Predictors of Adverse Events After Cardiac Surgery</brief_title>
	<detailed_description>This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Disease Susceptibility</mesh_term>
	<mesh_term>Genetic Predisposition to Disease</mesh_term>
	<criteria>Undergoing heart surgery Willing to provide consent Enrolled in a concurrent drug or device trial that precludes concurrent enrollment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>